Today (10/1/09) TLCR – Talceris Biotherapeutics IPO opened for trading and did quite well for this weak trading session. See stats below..
TLCR – Talceris Biotherapeutics
Shares Offered: 44.7M
Revised Shares: 50.0M
Initial Range: $18-20
Date Priced: 10/01/09 (Thurs)
Priced: $19.00
Opened: $20.00
Closed: $21.15 (+$2.15, +11.32%, up another $0.33 in after-hours)
Lead Underwriters: Morgan Stanley, Goldman Sachs, Citigroup and JP Morgan
Description: Talceris Biotheraputics manufactures plasma-derived protein therapies for chronic and acute conditions.
